Alphabet Inc.

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 7, 2025), Alphabet Inc. reported 40 stock positions worth $1.7 billion. Its top holding was Gitlab Class A (GTLB) at 20.0% of the portfolio, followed by Freshworks Class A (FRSH, 15.3%) and Arm Holdings PLC-ADR (ARM, 14.1%). Compared with Q3 2024, it sold out of 2 and reduced 2. The biggest sale was Gitlab Class A (GTLB, shares −38%).

Most Recent 13F
Q2 2026
Location
Mountain View, CA
CIK
0001652044
Portfolio Value
$1.7B (Q4 2024)
SEC Filing
0001652044-25-000019 ↗ filed Feb 7, 2025

Holdings Value

0$20.0B$40.0B$60.0B$80.0B$100.0B Q1 2024: $2.5B Q1 2024 Q2 2024: $2.0B Q2 2024 Q3 2024: $1.8B Q3 2024 Q4 2024: $1.7B $1.7B Q4 2024 Q1 2025: $1.6B Q1 2025 Q2 2025: $2.1B Q2 2025 Q3 2025: $2.4B Q3 2025 Q4 2025: $2.6B Q4 2025 Q1 2026: $4.0B Q1 2026 Q2 2026: $99.1B Q2 2026

Holdings 40 stocks · $1.7B
GTLB Gitlab Inc. Class A 19.98% 6,091,238 $343.2M Reduce -37.6%
FRSH Freshworks Inc. Class A 15.26% 16,206,643 $262.1M No change
ARM Arm Holdings PLC-ADR 14.08% 1,960,784 $241.9M No change
RVMD Revolution Medicines Inc. 10.53% 4,133,277 $180.8M Reduce -2.9%
CRWD CrowdStrike Holdings Inc. Class A 8.52% 427,895 $146.4M No change
PL Planet Labs PBC 7.51% 31,942,641 $129.0M No change
PATH Uipath Inc. Class A 5.21% 7,034,337 $89.4M No change
DXCM Dexcom Inc. 4.69% 1,036,937 $80.6M No change
VERV Verve Therapeutics Inc. 4.06% 12,349,086 $69.6M No change
TEM Tempus AI Inc. Class A 3.05% 1,551,102 $52.4M No change
PRME Prime Medicine Inc. 2.56% 15,062,498 $44.0M No change
VERA Vera Therapeutics Inc. 0.59% 241,264 $10.2M No change
GLUE Monte Rosa Therapeutics Inc. 0.59% 1,464,015 $10.2M No change
BEAM Beam Therapeutics Inc. 0.46% 321,604 $8.0M No change
OSCR Oscar Health Inc. Class A 0.38% 481,988 $6.5M No change
RLAY Relay Therapeutics Inc. 0.38% 1,568,753 $6.5M No change
SANA Sana Biotechnology Inc. 0.27% 2,812,500 $4.6M No change
DNTH Dianthus Therapeutics Inc. 0.26% 208,697 $4.5M No change
LYEL Lyell Immunopharma Inc. 0.22% 5,865,125 $3.8M No change
TCRX Tscan Therapeutics Inc. 0.19% 1,077,080 $3.3M No change
DM Desktop Metal Inc. Class A 0.15% 1,104,871 $2.6M No change
FHTX Foghorn Therapeutics Inc. 0.14% 500,901 $2.4M No change
BRNS Barinthus Biotherapeutics PL 0.11% 1,513,644 $1.8M No change
WGS Genedx Holdings Corp. 0.10% 22,711 $1.7M No change
AUTL Autolus Therapeutics PLC 0.10% 698,262 $1.6M No change
KRON Kronos Bio Inc. 0.08% 1,438,232 $1.4M No change
GUTS Fractyl Health Inc. 0.08% 662,584 $1.4M No change
TNYA Tenaya Therapeutics Inc. 0.08% 915,705 $1.3M No change
EXAS Exact Sciences Corp. 0.08% 23,205 $1.3M No change
TSHA Taysha Gene Therapies Inc. 0.06% 640,882 $1.1M No change
SPRO Spero Therapeutics Inc. 0.05% 889,979 $917K No change
BHILQ Benson Hill Inc. 0.05% 438,635 $864K No change
HYPR Hyperfine Inc. 0.05% 898,720 $791K No change
RANI Rani Therapeutics Holdings Class A 0.04% 448,492 $614K No change
QUINCE THERAPEUTICS INC 0.02% 189,122 $354K No change
ALEC Alector Inc. 0.02% 175,866 $332K No change
FULC Fulcrum Therapeutics Inc. 0.00% 14,262 $67K No change
RGEN Repligen Corp. 0.00% 383 $55K No change
HLTHQ Cue Health Inc. 0.00% 27,000 $0 No change
NVTAQ Invitae Corp. 0.00% 235,606 $0 No change

Portfolio Sells Q3 2024 → Q4 2024
GTLB Gitlab Inc. Class A Reduce -37.6% 19.98% −7.32
SNOW Snowflake Inc. Sold out 0.00% −0.71
RAPT THERAPEUTICS INC Sold out 0.00% −0.06
RVMD Revolution Medicines Inc. Reduce -2.9% 10.53% +0.05

Portfolio Buys Q3 2024 → Q4 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 28$99.1BSPCX, PL, ASTS, CME, ARM
Q1 2026 26$4.0BCME, PL, ASTS, RVMD, ARM
Q4 2025 29$2.6BASTS, PL, RVMD, ARM, FRSH
Q3 2025 37$2.4BASTS, PL, ARM, MTSR, RVMD
Q2 2025 36$2.1BASTS, ARM, FRSH, PL, RVMD
Q1 2025 40$1.6BFRSH, ARM, ASTS, RVMD, MTSR
Q4 2024 40$1.7BGTLB, FRSH, ARM, RVMD, CRWD
Q3 2024 42$1.8BGTLB, ARM, RVMD, FRSH, CRWD
Q2 2024 42$2.0BGTLB, ARM, RVMD, CRWD, FRSH
Q1 2024 43$2.5BGTLB, CRWD, DXCM, ARM, FRSH